Vimarsana
Biggest News Aggregation in the World

Page 2 - Integrity Applications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Integrity Applications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Integrity Applications Today - Breaking & Trending Today

Analyzing Intelligent Bio Solutions (NASDAQ:INBS) & GlucoTrack (NASDAQ:GCTK) - Vimarsana News

Analyzing Intelligent Bio Solutions (NASDAQ:INBS) & GlucoTrack (NASDAQ:GCTK)

GlucoTrack (NASDAQ:GCTK – Get Free Report) and Intelligent Bio Solutions (NASDAQ:INBS – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership. Earnings and Valuation This table compares GlucoTrack […]

Comparing Atrion (NASDAQ:ATRI) & GlucoTrack (NASDAQ:GCTK) - Vimarsana News

Comparing Atrion (NASDAQ:ATRI) & GlucoTrack (NASDAQ:GCTK)

Atrion (NASDAQ:ATRI – Get Free Report) and GlucoTrack (NASDAQ:GCTK – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, profitability, valuation, dividends and earnings. Volatility and Risk Atrion has a beta of 0.53, […]

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ERIN CARTER TO BOARD OF DIRECTORS - Vimarsana News

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ERIN CARTER TO BOARD OF DIRECTORS

Rutherford, NJ, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with diabetes and prediabetes, announced today that it has appointed Erin Carter to its Board of Directors and as Chair of its Audit Committee, effective immediately. Ms. Carter brings 30 years of executive level finance experience in the medical device industry. From 2012 until March of 2023, she held va

Source: yahoo.com
GLUCOTRACK ANNOUNCES POSITIVE DATA FROM FEASIBILITY STUDY FOR IMPLANTABLE CONTINUOUS GLUCOSE MONITOR - Vimarsana News

GLUCOTRACK ANNOUNCES POSITIVE DATA FROM FEASIBILITY STUDY FOR IMPLANTABLE CONTINUOUS GLUCOSE MONITOR

25.07.2023 - Rutherford, NJ, July 25, 2023 (GLOBE NEWSWIRE) - - Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device and digital health platform company focused on diabetes and prediabetes, announced today the completion and ...

Global Point-of-Care Glucose Testing Market 2023 to 2030: - Vimarsana News

Global Point-of-Care Glucose Testing Market 2023 to 2030:

Dublin, July 05, 2023 (GLOBE NEWSWIRE) -- The "Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report By Product (Accu Check Aviva...